Optimizing CAR Structures to Enhance Efficacy in Solid Tumors - Moving from Linear to Lateral Architectures

Optimizing CAR Structures to Enhance Efficacy in Solid Tumors - Moving from Linear to Lateral Architectures

Explore a one-hour webinar presented by Marc Davies, PhD and Stacie Chvatal, PhD on optimizing Chimeric Antigen Receptor (CAR) structures to enhance efficacy in solid tumors. Delve into the transition from linear to lateral architectures in CAR T-cell therapy. Learn about the revolutionary impact of second-generation CAR T-cells in treating B-cell and plasma cell malignancies, and understand the challenges faced in applying this therapy to solid tumors. Gain insights into potential strategies for improving CAR T-cell efficacy against a broader range of cancer types.